Venture Overview Updated in New Company Page on LinkedIn: Leaders in Pharmaceutical Business Intelligence
Curator: Aviva Lev-Ari, PhD, RN
- LPBI Group’s Company’s Page on LinkedIn
- e-Scientific Publishing: The Competitive Advantage of a Powerhouse for Curation of Scientific Findings and Methodology Development for e-Scientific Publishing – LPBI Group, A Case in Point
Leaders in Pharmaceutical Business Intelligence, a US based Holding Company, headquartered in Boston, MA. It has Six Ventures and operates Globally.
- Specialties
e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical, Funding, Deals & Partnerships, BioMedical e-Books e-Series, PRESS Coverage International Biotech Conferences, IP Invented HERE!, HealthCare Investors, International Scientific Delegations of Patent Holders
- Website http://pharmaceuticalintelligence.com
- Twitter.com: @pharma_BI, @AVIVA1950
- Industry Pharmaceutical and Medical Devices
- Type Privately Held
- Company Size 11-50 Affiliated PhDs, MDs, MD/PhDs, PharmDs, MBAs
- Founded 2/2012
- Director and Founder: Aviva Lev-Ari, PhD, RN
- VENTURE #1: e-Publishing: Medicine, HealthCare, Life Sciences, BioMed, Pharmaceutical– Open Access Online Scientific Journal http://pharmaceuticalintelligence.com
Highlights: 588,887 Journal views; 2,798 Life Sciences & Medicine articles; 336 Research Categories; 6,784 Tags
- VENTURE #2: BioMedical e-Books e-Series: Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine http://pharmaceuticalintelligence.com/biomed-e-books/
Highlights: To be published by Amazon-Kindle.com in 2015 – Seven Volumes:
Four e-Books in Genomics & Medicine
o Genomics and Individualized Medicine
o Cancer and Genomics
o Metabolomics & Genetics
o Milestones in Physiology – Discoveries in Medicine, Genomics and Therapeutics
Three e-Books in Cardiovascular Diseases
o Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
o Etiologies of CVD: Epigenetics, Genetics & Genomics
o Therapeutic Promise: CVD, Regenerative & Translational Medicine
[Volume one is on Amazon.com http://www.amazon.com/dp/B00DINFFYC]
- VENTURE #3: HealthCare Investor’s Corner http://pharmaceuticalintelligence.com/options/
Highlights: Business Intelligence and Analytics on US-based Institutional Investments in Global Medical Devices and Oncology Drugs
- VENTURE #4: Funding, Deals & Partnerships http://pharmaceuticalintelligence.com/joint-ventures/
International Scientific Delegations http://pharmaceuticalintelligence.com/scientific-delegation
Highlights:
Corporate Clients for our Services: Funding Medical Devices Development & Diagnostics, Biologics and Platforms
o MEDICAL DEVICES & DIAGNOSTICS
o BIOLOGICS
o BIOTECHNOLOGY
o PLATFORM – Global Relational DB: ONCOLOGY DRUGS and CLINICAL TRIALS
- VENTURE #5: IP Invented HERE!
Highlights: Five Projects in Progress – Pre-Patent Application (Dr. Pearlman’s IP)
- VENTURE # 6: Real Time PRESS Coverage International Biotech Conferences http://pharmaceuticalintelligence.com/press-coverage/
Highlights: Twelve Leading Biotech Conferences covered 2013-15
Leave a Reply